- Home
- GDRX vs HRMY Comparison
GDRX vs HRMY Comparison
Compare GDRX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDRX
- HRMY
- Stock Information
- Founded
- GDRX 2011
- HRMY 2017
- Country
- GDRX United States
- HRMY United States
- Employees
- GDRX N/A
- HRMY N/A
- Industry
- GDRX Retail: Computer Software & Peripheral Equipment
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- GDRX Technology
- HRMY Health Care
- Exchange
- GDRX Nasdaq
- HRMY Nasdaq
- Market Cap
- GDRX 1.7B
- HRMY 2.0B
- IPO Year
- GDRX 2020
- HRMY 2020
- Fundamental
- Price
- GDRX $4.57
- HRMY $39.05
- Analyst Decision
- GDRX Buy
- HRMY Strong Buy
- Analyst Count
- GDRX 15
- HRMY 8
- Target Price
- GDRX $8.75
- HRMY $55.00
- AVG Volume (30 Days)
- GDRX 1.3M
- HRMY 593.9K
- Earning Date
- GDRX 02-27-2025
- HRMY 02-20-2025
- Dividend Yield
- GDRX N/A
- HRMY N/A
- EPS Growth
- GDRX N/A
- HRMY N/A
- EPS
- GDRX N/A
- HRMY 2.11
- Revenue
- GDRX $790,385,000.00
- HRMY $681,879,000.00
- Revenue This Year
- GDRX $7.89
- HRMY $24.79
- Revenue Next Year
- GDRX $4.04
- HRMY $19.00
- P/E Ratio
- GDRX N/A
- HRMY $18.55
- Revenue Growth
- GDRX 7.14
- HRMY 25.83
- 52 Week Low
- GDRX $4.09
- HRMY $28.14
- 52 Week High
- GDRX $9.26
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- GDRX 50.35
- HRMY 71.30
- Support Level
- GDRX $4.12
- HRMY $35.72
- Resistance Level
- GDRX $4.57
- HRMY $37.16
- Average True Range (ATR)
- GDRX 0.22
- HRMY 1.29
- MACD
- GDRX 0.03
- HRMY 0.48
- Stochastic Oscillator
- GDRX 71.65
- HRMY 92.25
About GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.